Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of the Neurological Sciences|May 17, 2026
Word-deafness phenotype in logopenic variant primary progressive aphasia: A multicenter retrospective case seriesShun Akaike, Kazuhiro Horiuchi, Kazuyoshi Shinpo, et al.
Internal Medicine (Tokyo, Japan)|September 18, 2023
Clinical Characteristics of Patients with Cryptococcal Meningitis in Hokkaido: A Case SeriesMonami Tarisawa, Takahiro Kano, Tomoki Ishimaru, et al.
Journal of the Neurological Sciences|September 17, 2022
Clinical features of anti-mitochondrial M2 antibody-positive myositis: case series of 17 patientsAzusa Nagai, Toshiyuki Nagai, Hiroaki Yaguchi, et al.
Immunological Medicine|June 18, 2026
Anti-striated muscle antibody positive anti-PD-1 antibody related myositis and cardiomyositis: an instructive autopsy case report with discussion for trigger of irAEAyaka Kamada, Taichi Nomura, Terufumi Kubo, et al.
Clinical Neurology and Neurosurgery|February 7, 2024
Reliability of the unified multiple system atrophy rating scale using the telephoneMasaaki Matsushima, Azusa Nagai, Rie Nomachi, et al.
Archives of Neurology|July 11, 2007
Limb-girdle muscular dystrophy due to emerin gene mutationsShigehisa Ura, Yukiko K Hayashi, Kanako Goto, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 16, 2018
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 14, 2018
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 8, 2019
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 8, 2018
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Pageof 3